| 1.37 0.27 (24.55%) | 04-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.64 |
1-year : | 1.92 |
| Resists | First : | 1.4 |
Second : | 1.64 |
| Pivot price | 0.98 |
|||
| Supports | First : | 0.84 |
Second : | 0.5 |
| MAs | MA(5) : | 0.99 |
MA(20) : | 1 |
| MA(100) : | 1.36 |
MA(250) : | 1.4 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 90.9 |
D(3) : | 67 |
| RSI | RSI(14): 61.2 |
|||
| 52-week | High : | 3.22 | Low : | 0.5 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ LICN ] has closed It is unclear right now based on current values. 64.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.41 - 1.42 | 1.42 - 1.42 |
| Low: | 1.14 - 1.14 | 1.14 - 1.15 |
| Close: | 1.36 - 1.37 | 1.37 - 1.38 |
Lichen China Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company offers financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as sale of teaching and learning materials. It also provides Lichen Education Accounting Practice System V1.0, a financial and taxation training software, and academic affairs management system to partnered institutions under the partnership agreements, as well as offers software installation, training, and after sales technical and maintenance support services. The company was founded in 2004 and is based in Jinjiang, China.
Tue, 23 Apr 2024
MSN - MSN
Tue, 23 Apr 2024
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.69% - Investing.com India
Tue, 23 Apr 2024
US Stocks Higher; PepsiCo Posts Upbeat Earnings - Abeona Therapeutics (NASDAQ:ABEO), Cyngn (NASDAQ:CYN) - Benzinga
Sat, 06 Apr 2024
Lichen China Limited's (NASDAQ:LICN) Price Is Right But Growth Is Lacking - Simply Wall St
Mon, 25 Mar 2024
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid ... - Markets Insider
Thu, 14 Mar 2024
Lichen China launches operations in Singapore By Investing.com - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Industrials
|
|
|
Industry:
Specialty Business Services
|
|
| Shares Out | 18 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 63.6 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 63 (K) |
| Shares Short P.Month | 73 (K) |
| EPS | 0.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.31 |
| Profit Margin | 20.9 % |
| Operating Margin | 39.4 % |
| Return on Assets (ttm) | 13.6 % |
| Return on Equity (ttm) | 16.2 % |
| Qtrly Rev. Growth | 35 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 2.16 |
| EBITDA (p.s.) | 0.7 |
| Qtrly Earnings Growth | 69.9 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | 4.28 |
| PEG Ratio | 0 |
| Price to Book value | 0.59 |
| Price to Sales | 0.63 |
| Price to Cash Flow | 45.18 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|